CSX vs OGEN · P/E 19, rev $14.09B vs rev $37.7K
CSX Corporation (CSX) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the CSX and OGEN stock pages for the full models.
Not investment advice.